tiprankstipranks
NeuroSense reports Q1 EPS (35c) vs. (25c) last year
PremiumThe FlyNeuroSense reports Q1 EPS (35c) vs. (25c) last year
14d ago
NeuroSense Management Provides Corporate Update and First Quarter 2024 Financial Results
PremiumPress Releases
NeuroSense Management Provides Corporate Update and First Quarter 2024 Financial Results
14d ago
NeuroSense Challenges Nasdaq Delisting Notice
PremiumCompany Announcements
NeuroSense Challenges Nasdaq Delisting Notice
16d ago
NeuroSense Reveals Promising ALS Therapy Progress
PremiumCompany AnnouncementsNeuroSense Reveals Promising ALS Therapy Progress
2M ago
NeuroSense Optimizes ALS Trial with Machine Learning
PremiumCompany Announcements
NeuroSense Optimizes ALS Trial with Machine Learning
2M ago
NeuroSense partners with PhaseV for machine learning in ALS Phase 3 trial
PremiumThe Fly
NeuroSense partners with PhaseV for machine learning in ALS Phase 3 trial
2M ago
NeuroSense reports Phase 2b neurology results of PrimeC
PremiumThe FlyNeuroSense reports Phase 2b neurology results of PrimeC
3M ago
NeuroSense Launches Pre-Funded Warrants Offering
PremiumCompany Announcements
NeuroSense Launches Pre-Funded Warrants Offering
3M ago
NeuroSense Advances ALS Therapy with Promising Trials
PremiumCompany Announcements
NeuroSense Advances ALS Therapy with Promising Trials
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100